112 related articles for article (PubMed ID: 7459342)
1. Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides.
Oldberg A; Heldin CH; Wasteson A; Busch C; Höök M
Biochemistry; 1980 Dec; 19(25):5755-62. PubMed ID: 7459342
[TBL] [Abstract][Full Text] [Related]
2. Purification and properties of human platelet heparitinase.
Oosta GM; Favreau LV; Beeler DL; Rosenberg RD
J Biol Chem; 1982 Oct; 257(19):11249-55. PubMed ID: 7118882
[TBL] [Abstract][Full Text] [Related]
3. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase.
Yahalom J; Eldor A; Fuks Z; Vlodavsky I
J Clin Invest; 1984 Nov; 74(5):1842-9. PubMed ID: 6389600
[TBL] [Abstract][Full Text] [Related]
4. Examination of the substrate specificity of heparin and heparan sulfate lyases.
Linhardt RJ; Turnbull JE; Wang HM; Loganathan D; Gallagher JT
Biochemistry; 1990 Mar; 29(10):2611-7. PubMed ID: 2334685
[TBL] [Abstract][Full Text] [Related]
5. Human platelet heparanase: purification, characterization and catalytic activity.
Freeman C; Parish CR
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
[TBL] [Abstract][Full Text] [Related]
6. Activation of platelet heparitinase by tumor cell-derived factors.
Haimovitz-Friedman A; Falcone DJ; Eldor A; Schirrmacher V; Vlodavsky I; Fuks Z
Blood; 1991 Aug; 78(3):789-96. PubMed ID: 1859891
[TBL] [Abstract][Full Text] [Related]
7. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy.
Nader HB; Porcionatto MA; Tersariol IL; Pinhal MA; Oliveira FW; Moraes CT; Dietrich CP
J Biol Chem; 1990 Oct; 265(28):16807-13. PubMed ID: 2211596
[TBL] [Abstract][Full Text] [Related]
8. Purification of heparinase and heparitinase by affinity chromatography on glycosaminoglycan-bound AH-Sepharose 4B.
Ototani N; Kikuchi M; Yosizawa Z
Carbohydr Res; 1981 Feb; 88(2):291-303. PubMed ID: 7214377
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic depolymerization of heparin-related polysaccharides. Substrate specificities of mouse mastocytoma and human platelet endo-beta-D-glucuronidases.
Thunberg L; Bäckström G; Wasteson A; Robinson HC; Ogren S; Lindahl U
J Biol Chem; 1982 Sep; 257(17):10278-82. PubMed ID: 7107605
[TBL] [Abstract][Full Text] [Related]
10. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan.
Nader HB; Dietrich CP; Buonassisi V; Colburn P
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3565-9. PubMed ID: 2954157
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.
Castellot JJ; Favreau LV; Karnovsky MJ; Rosenberg RD
J Biol Chem; 1982 Oct; 257(19):11256-60. PubMed ID: 7118883
[TBL] [Abstract][Full Text] [Related]
12. Partial sequence of human platelet heparitinase and evidence of its ability to polymerize.
Gonzalez-Stawinski GV; Parker W; Holzknecht ZE; Huber NS; Platt JL
Biochim Biophys Acta; 1999 Jan; 1429(2):431-8. PubMed ID: 9989228
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.
Bar-Ner M; Eldor A; Wasserman L; Matzner Y; Cohen IR; Fuks Z; Vlodavsky I
Blood; 1987 Aug; 70(2):551-7. PubMed ID: 2955820
[TBL] [Abstract][Full Text] [Related]
14. Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate.
Sewell RF; Brenchley PE; Mallick NP
Biochem J; 1989 Dec; 264(3):777-83. PubMed ID: 2533499
[TBL] [Abstract][Full Text] [Related]
15. Structural studies on the oligosaccharides isolated from bovine kidney heparan sulphate and characterization of bacterial heparitinases used as substrates.
Sugahara K; Tohno-oka R; Yamada S; Khoo KH; Morris HR; Dell A
Glycobiology; 1994 Aug; 4(4):535-44. PubMed ID: 7827415
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
Bashkin P; Doctrow S; Klagsbrun M; Svahn CM; Folkman J; Vlodavsky I
Biochemistry; 1989 Feb; 28(4):1737-43. PubMed ID: 2541764
[TBL] [Abstract][Full Text] [Related]
17. Degradative removal of heparan sulfate from the surface of an ascites hepatoma, AH 66, by heparitinase.
Ohkubo Y; Funakoshi I; Yamashina I
J Biochem; 1981 Jan; 89(1):161-7. PubMed ID: 6452448
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of a heparan sulfate-degrading endoglucuronidase from human placenta.
Klein U; von Figura K
Hoppe Seylers Z Physiol Chem; 1979 Oct; 360(10):1465-71. PubMed ID: 159251
[TBL] [Abstract][Full Text] [Related]
19. Platelet heparitinase.
Rosenberg RD
Methods Enzymol; 1989; 169():342-51. PubMed ID: 2541312
[No Abstract] [Full Text] [Related]
20. Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.
Khoory MS; Nesheim ME; Bowie EJ; Mann KG
J Clin Invest; 1980 Mar; 65(3):666-74. PubMed ID: 6444419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
